You are here
- Home
Total number of clinical trials
-
expand
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
- Study Id
- ICP-103-307
- Disease
- irritable bowel syndrome
- Drug Name
- AstraZeneca Gastrointestinal Development Drugs
- Study Name
- D5630C00001
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated patients Assesment of the correlation between Body Mass Index and recurrence among Zoladex treated prostate cancer patients
- Study Id
- NIS-OHU-ZOL-2009-1
- Disease
- prostate cancer
- Drug Name
- Zoladex
- Study Name
- NIS-OHU-ZOL/2009/1
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Double-blind Placebo-controlled, Randomised, Single centre, First Time in Man Study to evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Inhaled Doses of AZD7624 in Healthy Subjects
- Study Id
- D2550C00001
- Disease
- pharmacodynamics, pharmacokinetics
- Drug Name
- AstraZeneca Respiratory and Inflammation Development Drugs
- Study Name
- D2550C00001
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Randomised, Double-Blind, 2-Period Crossover Study to Assess the Effect of Steady-State AZD6140 on the Pharmacokinetics of a Single Oral 500-mg Dose of Tolbutamide, a Substrate of CYP2C9, in Healthy Male and Female Volunteers.
- Study Id
- D5130C00051
- Disease
- acute coronary syndrome
- Drug Name
- Brilinta
- Recruiting Status
- Closed
- Protocol
-
Apr 16, 2013
- Report Status
- Not Available
-
expand
A Phase I/II Multi-centre Study of AZD8931 in Combination with Weekly Paclitaxel to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy in Patients with Advanced Solid Tumours and in a Selected Population with Low HER2-expressing Locally Recurrent and/or Metastatic Breast Cancer (THYME)
- Study Id
- D0102C00003
- Disease
- solid tumour
- Drug Name
- AZD8931
- Study Name
- D0102C00003
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Phase 1, Single Centre, Double-blind, Randomised, Placebo-controlled, Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics after Administration of Multiple Ascending (MAD) Once Weekly Inhaled Doses of AZD8848 in Healthy Subjects
- Study Id
- D0542C00002
- Disease
- pharmacokinetics
- Drug Name
- AZD8848
- Study Name
- D0542C00002
- Recruiting Status
- Not Yet Recruiting
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Multicentre, Retrospective Chart Review Study to Characterise Gefitinib Usage and Outcomes in Routine Treatment
- Study Id
- NIS-OGB-IRE-2012/1
- Disease
- lung cancer
- Drug Name
- IRESSA
- Study Name
- NIS-OGB-IRE-2012/1
- Recruiting Status
- Not Yet Recruiting
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Phase I, Randomized, DoubleBlind Placebo-Controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Inhaled Doses (MAD) of AZD7624 to Healthy Subjects and Patients with COPD
- Study Id
- D2550C00002
- Disease
- chronic obstructive pulmonary disease
- Study Name
- D2550C00002
- Recruiting Status
- Not Yet Recruiting
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Phase I, Open-Label, Multi-centre Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of AZD8330 in Patients With Advanced Malignancies
- Study Id
- D1536C00001
- Disease
- cancer
- Drug Name
- AZD8330
- Study Name
- D1536C00001
- Recruiting Status
- Closed
- Protocol
-
Feb 6, 2007
- Report Status
- Not Available
-
expand
A cohort study on the association between acid-suppressing drugs in pregnancy and asthma in the offspring
- Study Id
- D9612N00018
- Disease
- asthma
- Drug Name
- non drug study (respiratory)
- Study Name
- D9612N00018
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
